International Biotechnology Trust PLC Supernus Pharmaceuticals, Inc. Transaction History

International Biotechnology Trust PLC

$295 Million
Q3 2023

A detailed history of International Biotechnology Trust PLC transactions in Supernus Pharmaceuticals, Inc. stock. As of the latest transaction made, International Biotechnology Trust PLC holds 426,500 shares of SUPN stock, worth $16.4 Million. This represents 3.99% of its overall portfolio holdings.

Number of Shares

426,500

Previous 523,500 18.53%

Holding current value

$16.4 Million

Previous $15.7 Million 25.28%

% of portfolio

3.99%

Previous 4.91%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$27.57 - $32.91 $2.67 Million - $3.19 Million	-97,000 Reduced 18.53%	426,500 $11.8 Million
Q2 2023 Aug 08, 2023	BUY	$29.91 - $38.73 $2.99 Million - $3.87 Million	100,000 Added 23.61%	523,500 $15.7 Million
Q1 2023 May 18, 2023	BUY	$34.93 - $42.03 $1.4 Million - $1.68 Million	40,000 Added 10.43%	423,500 $15.3 Million
Q4 2022 Feb 01, 2023	BUY	$31.09 - $37.88 $2.67 Million - $3.26 Million	86,000 Added 28.91%	383,500 $13.7 Million
Q3 2022 Nov 08, 2022	BUY	$28.79 - $35.41 $8.32 Million - $10.2 Million	288,896 Added 3357.69%	297,500 $10.1 Million
Q2 2022 Aug 16, 2022	SELL	$25.33 - $34.25 $7.32 Million - $9.89 Million	-288,896 Reduced 97.11%	8,604 $298 Million
Q3 2021 Nov 12, 2021	BUY	$23.54 - $31.39 $2.24 Million - $2.98 Million	95,064 Added 46.96%	297,500 $7.93 Million
Q2 2021 Aug 11, 2021	BUY	$26.72 - $33.19 $5.41 Million - $6.72 Million	202,436 New	202,436 $6.23 Million
Q1 2020 May 18, 2020	SELL	$14.45 - $24.69 $288,320 - $492,639	-19,953 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$29.96 - $38.87 $2.1 Million - $2.72 Million	-70,000 Reduced 77.82%	19,953 $659,000
Q1 2019 May 14, 2019	BUY	$32.77 - $41.99 $2.26 Million - $2.9 Million	69,000 Added 329.31%	89,953 $3.15 Million
Q3 2018 Nov 14, 2018	BUY	$42.7 - $56.55 $894,693 - $1.18 Million	20,953 New	20,953 $809,000
Q3 2018 Nov 13, 2018	SELL	$42.7 - $56.55 $894,693 - $1.18 Million	-20,953 Closed	0 $0
Q2 2017 Mar 02, 2018	SELL	N/A	-179,047 Reduced 89.52%	20,953 $902,000
Q1 2017 Mar 02, 2018	BUY	N/A	200,000	200,000 $6.25 Million

Others Institutions Holding SUPN

# of Institutions

290

Shares Held

60.7M

Call Options Held

27.7K

Put Options Held

11.3K

View Full List

About SUPERNUS PHARMACEUTICALS, INC.

Ticker SUPN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 53,495,300
Market Cap $2.05B
Description
Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...

More about SUPN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of International Biotechnology Trust PLC, based on Form 13F filings with the SEC.

News

Stay updated on International Biotechnology Trust PLC with notifications on news.

Account

International Biotechnology Trust PLC Supernus Pharmaceuticals, Inc. Transaction History